DCGI tells manufacturers, exporters not to submit same batch no. of cough syrup to two different laboratories

Safeguarding public health, through a recent notification, the Drug Controller General of India (DCGI) has notified all drug manufacturers' associations and exporters not to submit the same batch of cough syrup to more than one laboratory at a time, as this practice is highly objectionable and not acceptable from a regulatory standpoint.

This came when two different government laboratories accredited by the National Accreditation Board for Testing and Calibration (NABL) received cough syrup from the same manufacturer/exporter with the same batch number for testing purposes.

For more details, check out the link given below:

Do Not Submit Same Batch No. Of Cough Syrup To Two Different Laboratories: DCGI Tells Manufacturers, Exporters